Tango Therapeutics, Inc. (TNGX) Financials

TNGX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.1 billion 49.3 million
March 31, 2026 435.8 million 44.3 million
Dec. 31, 2025 398.7 million 52.5 million
Sept. 30, 2025 210.1 million 50.1 million

TNGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -38.9 million 16.9 million
March 31, 2026 -44.4 million 10.8 million
Dec. 31, 2025 -29.9 million 6.0 million
Sept. 30, 2025 -31.1 million 6.6 million

TNGX Net Income

No data available :(

TNGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 1.0 billion 29.0 million -
March 31, 2026 379.8 million 30.0 million 2.8 million
Dec. 31, 2025 343.1 million - 33.6 million
Sept. 30, 2025 152.8 million - 34.8 million

TNGX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 149.9 million
March 31, 2026 143.6 million
Dec. 31, 2025 116.2 million
Sept. 30, 2025 111.0 million

TNGX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 37.2 million 22.6 million -
March 31, 2026 2000 33.1 million 15.2 million -
Dec. 31, 2025 222000 33.3 million 9.8 million -
Sept. 30, 2025 151000 30.8 million 8.9 million -

TNGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 463000
Dec. 31, 2025 - 479000
Sept. 30, 2025 53.8 million 555000

TNGX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

TNGX

Price: $25.60

52 week price:
6.25
34.39

Earnings Per Share: -0.82 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 179400

Market Capitalization: 4.3 billion

Links: